Thase, M.E., Youakim, J.M., Skuban, A., et al. (2015) Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder: A Phase 3, Randomized, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants. Journal of Clinical Psychiatry, 76, 1224-1231.